214 related articles for article (PubMed ID: 19763524)
1. Post-translationally modified T cell epitopes: immune recognition and immunotherapy.
Petersen J; Purcell AW; Rossjohn J
J Mol Med (Berl); 2009 Nov; 87(11):1045-51. PubMed ID: 19763524
[TBL] [Abstract][Full Text] [Related]
2. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
4. T cell epitopes and post-translationally modified epitopes in type 1 diabetes.
McGinty JW; Marré ML; Bajzik V; Piganelli JD; James EA
Curr Diab Rep; 2015 Nov; 15(11):90. PubMed ID: 26370701
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53.
Kumai T; Ishibashi K; Oikawa K; Matsuda Y; Aoki N; Kimura S; Hayashi S; Kitada M; Harabuchi Y; Celis E; Kobayashi H
Cancer Immunol Immunother; 2014 May; 63(5):469-78. PubMed ID: 24633296
[TBL] [Abstract][Full Text] [Related]
6. Post-Translational Peptide Splicing and T Cell Responses.
Mishto M; Liepe J
Trends Immunol; 2017 Dec; 38(12):904-915. PubMed ID: 28830734
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
[TBL] [Abstract][Full Text] [Related]
8. Post-translational modifications of naturally processed MHC-binding epitopes.
Engelhard VH; Altrich-Vanlith M; Ostankovitch M; Zarling AL
Curr Opin Immunol; 2006 Feb; 18(1):92-7. PubMed ID: 16343885
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.
Kamphuis S; Kuis W; de Jager W; Teklenburg G; Massa M; Gordon G; Boerhof M; Rijkers GT; Uiterwaal CS; Otten HG; Sette A; Albani S; Prakken BJ
Lancet; 2005 Jul 2-8; 366(9479):50-6. PubMed ID: 15993233
[TBL] [Abstract][Full Text] [Related]
10. Post-translational protein modifications in antigen recognition and autoimmunity.
Doyle HA; Mamula MJ
Trends Immunol; 2001 Aug; 22(8):443-9. PubMed ID: 11473834
[TBL] [Abstract][Full Text] [Related]
11. Functional Recognition by CD8+ T Cells of Epitopes with Amino Acid Variations Outside Known MHC Anchor or T Cell Receptor Recognition Residues.
Wilson KL; Xiang SD; Plebanski M
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630213
[TBL] [Abstract][Full Text] [Related]
12. Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4
Marre ML; McGinty JW; Chow IT; DeNicola ME; Beck NW; Kent SC; Powers AC; Bottino R; Harlan DM; Greenbaum CJ; Kwok WW; Piganelli JD; James EA
Diabetes; 2018 Jul; 67(7):1356-1368. PubMed ID: 29654212
[TBL] [Abstract][Full Text] [Related]
13. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
14. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.
Murata K; Nakatsugawa M; Rahman MA; Nguyen LT; Millar DG; Mulder DT; Sugata K; Saijo H; Matsunaga Y; Kagoya Y; Guo T; Anczurowski M; Wang CH; Burt BD; Ly D; Saso K; Easson A; Goldstein DP; Reedijk M; Ghazarian D; Pugh TJ; Butler MO; Mak TW; Ohashi PS; Hirano N
Elife; 2020 Apr; 9():. PubMed ID: 32314731
[TBL] [Abstract][Full Text] [Related]
15. Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
Olvera A; Cedeño S; Llano A; Mothe B; Sanchez J; Arsequell G; Brander C
Front Immunol; 2020; 11():573928. PubMed ID: 33552045
[TBL] [Abstract][Full Text] [Related]
16. Immune recognition of citrullinated epitopes.
Nguyen H; James EA
Immunology; 2016 Oct; 149(2):131-8. PubMed ID: 27531825
[TBL] [Abstract][Full Text] [Related]
17. MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts.
Provenzano M; Panelli MC; Mocellin S; Bracci L; Sais G; Stroncek DF; Spagnoli GC; Marincola FM
Trends Mol Med; 2006 Oct; 12(10):465-72. PubMed ID: 16962375
[TBL] [Abstract][Full Text] [Related]
18. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases.
Shepard ER; Wegner A; Hill EV; Burton BR; Aerts S; Schurgers E; Hoedemaekers B; Ng STH; Streeter HB; Jansson L; Wraith DC
Front Immunol; 2021; 12():654201. PubMed ID: 33936079
[TBL] [Abstract][Full Text] [Related]
19. Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen.
Li Y; Zhou W; Du J; Jiang C; Xie X; Xue T; He Y
Cancer Immunol Immunother; 2015 Feb; 64(2):259-69. PubMed ID: 25376540
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modifications such as citrullination are excellent targets for cancer therapy.
Brentville VA; Vankemmelbeke M; Metheringham RL; Durrant LG
Semin Immunol; 2020 Feb; 47():101393. PubMed ID: 31932199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
